Cargando…
Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?
Chemotherapeutic drugs kill cancer cells or control their progression all over the patient's body, while radiation- and surgery-based treatments perform in a particular site. Based on their mechanisms of action, they are classified into different groups, including alkylating substrates, antimet...
Autores principales: | Mollaei, Mojtaba, Hassan, Zuhair Mohammad, Khorshidi, Fatemeh, Langroudi, Ladan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938256/ https://www.ncbi.nlm.nih.gov/pubmed/33684837 http://dx.doi.org/10.1016/j.tranon.2021.101056 |
Ejemplares similares
-
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells
por: Abrams, Stephen L., et al.
Publicado: (2017) -
Death of intestinal crypts and of their constituent cells after treatment by chemotherapeutic drugs.
por: Moore, J. V.
Publicado: (1984) -
The Surgeon and the Smartphone — is the Association Really Smart?
por: Gupta, Amit, et al.
Publicado: (2021) -
An Increase in Reactive Oxygen Species by Deregulation of ARNT Enhances Chemotherapeutic Drug-Induced Cancer Cell Death
por: Shieh, Jiunn-Min, et al.
Publicado: (2014) -
Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review
por: Zhai, Jiaqi, et al.
Publicado: (2023)